… This study reviewed the prevalence of uncommon EGFR mutations and their sensitivity to
EGFR… L858R mutations, indicating that they may benefit from EGFR-TKIs as a first-line therapy. …

… incidence of uncommon EGFR mutations and summarizes reported outcomes when treated
with EGFR-TKIs. … Exon 20 insertions in EGFR are the most prevalent of the uncommon EGFR …

… of uncommon EGFR mutations. The treatment for patients with NSCLC … uncommon EGFR
mutations remains a subject of debate and the sensitivity of uncommon EGFR mutations to …

… NSCLC, but its role in patients harboring EGFR mutations … of uncommon mutations to
currently available EGFR TKIs is … patients harboring uncommon EGFR mutations with currently …

… cases involve other mutation sites within or, … uncommon EGFR mutations (incidence ≤ 5%
each). Evidence on the efficacy of EGFR TKIs in NSCLC patients harboring uncommon EGFR …

… In conclusion, uncommon EGFR mutations may be associated with a poor outcome and the
… in cases of double uncommon mutations and such patients should be treated accordingly. …

… mutations in the EGFR. However, limited data are available regarding the activity of available
EGFR TKIs against uncommon EGFR mutations. … of patients with uncommon mutations for …

… “uncommon” mutations. We conducted a systematic literature review to identify evidence
on uncommon EGFR mutations … /metastatic NSCLC and uncommon EGFR mutations (excluding …

… of patients with multiple uncommon EGFR mutations and their sensitivity to EGFR TKIs. … of
EGFR TKIs in patients with uncommon EGFR mutations, which were defined as any mutation …

… ) mutations have stepped into the era of targeted therapy. … mutation and their outcome to
subsequent osimertinib in patients of advanced NSCLC harboring uncommon EGFR mutations. …